Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Biological & Pharmaceutical Bulletin|February 3, 2007
Rakicidin A: a hypoxia-selective cytotoxinYohko Yamazaki, Setsuko Kunimoto, Daishiro Ikeda
Biological & Pharmaceutical Bulletin|October 4, 2006
Anthracyclines, small-molecule inhibitors of hypoxia-inducible factor-1 alpha activationYohko Yamazaki, Yuki Hasebe, Kiyoshi Egawa, et al.
Biochemical and Biophysical Research Communications|January 27, 2009
Inhibitors of insulin-like growth factor-1 receptor tyrosine kinase are preferentially cytotoxic to nutrient-deprived pancreatic cancer cellsIsao Momose, Setsuko Kunimoto, Michiyo Osono, et al.
The Journal of Antibiotics|April 9, 2005
Absolute configuration of kigamicins A, C and DTetsuya Someno, Setsuko Kunimoto, Hikaru Nakamura, et al.
Biological & Pharmaceutical Bulletin|April 4, 2003
HIF-1-dependent VEGF reporter gene assay by a stable transformant of CHO cellsYohko Yamazaki, Kiyoshi Egawa, Kiyoshi Nose, et al.
Cancer Science|June 9, 2004
Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells' tolerance to nutrient starvationJie Lu, Setsuko Kunimoto, Yohko Yamazaki, et al.
The Journal of Antibiotics|March 16, 2004
Kigamicins, novel antitumor antibiotics. II. Structure determinationSetsuko Kunimoto, Tetsuya Someno, Yohko Yamazaki, et al.
The Journal of Antibiotics|July 13, 2006
Antitumor effect of kigamicin D on mouse tumor modelsToru Masuda, Shunichi Ohba, Manabu Kawada, et al.
The Journal of Antibiotics|July 13, 2006
Augmentation of cellular immunity by kigamicin DToru Masuda, Shunichi Ohba, Manabu Kawada, et al.
The Journal of Antibiotics|January 30, 2007
Inhibitory activity of the hypoxia-inducible factor-1 pathway by tartrolone CYohko Yamazaki, Tetsuya Someno, Kazuhisa Minamiguchi, et al.
Pageof 6